BioSpace News Archive

Business

Accuray To Report Fiscal 2018 Fourth Quarter And Full Year Financial Results On August 16, 2018

Accuray Incorporated will report results for its fourth quarter and fiscal year 2018 ended June 30, 2018 on Thursday, August 16, 2018 after the market close.

July 19, 2018
·
1 min read
Policy

FSD Pharma Enters Into Saskatchewan Wholesale Supply MOU of up to 5,000 Kilograms With High Tide Ventures

FSD Pharma Inc. announced that its wholly-owned subsidiary, FV Pharma Inc. (“FV Pharma”) has entered into a non-binding memorandum of understanding (“MOU”) with High Tide Ventures Inc.

July 19, 2018
·
5 min read
Genetown

Convergence 2018: Conference returns providing deeper insights on collaborative healthcare models for success in value-based care

Two-day conference will bring together senior leaders from across healthcare to explore the provider-payer convergence trends, strategies, and technologies transforming healthcare

July 19, 2018
·
3 min read
Novocure Announces 13 Presentations at American Society for Radiation Oncology 2018 Annual Meeting

The volume of Tumor Treating Fields presentations marks a record number of abstracts for Novocure at this conference

July 19, 2018
·
6 min read
Policy

EpigenCare Files Patent for Epigenetic Testing Towards Personalized Consumer Skincare

EpigenCare Inc. announced the filing of its patent application, “A method of creating epigenetic skin profile associated with skin quality.”

July 19, 2018
·
2 min read
Pharm Country

Boehringer Ingelheim and Lilly announce Tradjenta’s CARMELINA® cardiovascular outcome trial meets primary endpoint

Study supports long-term cardiovascular safety of Tradjenta® (linagliptin) in adults with type 2 diabetes

July 19, 2018
·
12 min read
Business

Leafbuyer Technologies Inc. Continues Strong Sales Growth

The company has announced a 50% sales increase from 4th Quarter 2017 compared to 4th Quarter 2018. June 2018 was the strongest sales growth in company history

July 19, 2018
·
1 min read
Business

GT Biopharma Inc. Announces Agreement with a Major Pharmaceutical Company to Study its Drug Candidate OXS-1550 in Combination With a Multi-Billion Dollar Oncology Drug

GT Biopharma Inc. (GTBP) and (Euronext Paris: GTBP.PA) announced today a Material Transfer Agreement (MTA) between a Major Pharmaceutical Company and Dr. Daniel Vallera, Director, Section of Molecular Cancer Therapeutics at the Masonic Cancer Center, University of Minnesota.

July 19, 2018
·
4 min read
Drug Development

Enteris BioPharma’s “Feasibility-to-Licensing” Partner, Cara Therapeutics, Doses First Patient in Phase 2 Trial of Peptelligence®-Engineered Oral KORSUVA™

Study to evaluate Oral KORSUVA (CR845/difelikefalin) for the Treatment of Pruritus in Stage III-V Chronic Kidney Disease (CKD) Patients

July 19, 2018
·
5 min read
Hemovent Reports “Stunning Results” from Completion of GLP Standardized in vivo Trial for Long-Term Use of Its Next-Gen ExtraCorporeal Membrane Oxygenation (ECMO) System Mobybox™

Key endpoints in all-six subjects — no hemolysis, no thrombosis at low anticoagulation and no functional device wear — will be used for CE mark registration and FDA submission of Mobybox™, the initial application of Hemovent’s Bionique™ platform.

July 19, 2018
·
2 min read